• Incident occurred on 5 June where patient's own embryo was incorrectly transferred
• Monash IVF has apologized to the affected couple and is conducting an internal investigation
• Interim additional verification processes and patient confirmation safeguards being implemented

Monash IVF Group Limited (ASX:MVF) has advised that an incident occurred at its Clayton laboratory on Thursday, 5 June, where a patient's own embryo was incorrectly transferred to that patient, contrary to the treatment plan which designated the transfer of an embryo of the patient's partner. Monash IVF has extended its sincere apologies to the affected couple and continues to support them. The company is conducting an internal investigation into the incident and has also expanded the scope of an independent review being conducted by Fiona McLeod AO SC in relation to a previous incident in Brisbane. Commencing immediately, Monash IVF will implement interim additional verification processes and patient confirmation safeguards over and above normal practice and electronic witness systems, to ensure patients and clinicians have every confidence in its processes. Monash IVF has disclosed the incident to the relevant assisted reproductive technology (ART) regulators and has notified its insurers, expecting the incident to fall within the scope of its insurance coverage. The update on profit guidance given by Monash IVF on 20 May 2025 remains unchanged.